SCHEMBL9957854

SCHEMBL9957854

CC(C)(Oc1ccc2c(c1)OCO2)C(=O)Nc1nc(OC(=O)O)c(Cl)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 5/20 0.53
▸ NPC1 O15118 4/20 0.42
▸ RAB9A P51151 4/20 0.42
▸ POLB P06746 2/20 0.42
▸ LMNA P02545 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41
▸ RELA Q04206 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GCK P35557 1/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ APEX1 P27695 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2660904 0.87 ADORA2A (0.54) ADORA2ANPC1RAB9APOLBLMNA
SCHEMBL2660974 0.84 GCK (0.59) ADORA2ANPC1RAB9APOLBLMNA
SCHEMBL9958116 0.81 NPC1 (0.52) ADORA2ANPC1RAB9ALMNAMAPT
SCHEMBL2661038 0.79 ADORA2A (0.56) ADORA2ANPC1RAB9APOLBLMNA
SCHEMBL2660257 0.77 GCK (0.53) ADORA2ANPC1RAB9APOLBMAPT
SCHEMBL2660820 0.77 NPC1 (0.53) ADORA2ANPC1RAB9ALMNAMAPT
SCHEMBL2660279 0.74 SMN1; SMN2 (0.52) ADORA2ANPC1RAB9ALMNAMAPT
SCHEMBL9958316 0.74 GCK (0.71) ADORA2APOLBGCKKMT2A
Ammonia Solution, Strong SCHEMBL19469522 0.69 PPARA (0.49) POLBLMNAMAPTSMN1; SMN2KMT2A
SCHEMBL2660231 0.69 ADORA2A (0.47) ADORA2ANPC1RAB9APOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125735-B1 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2012-06-27 — — EP claimed
Send feedback